Clinical Trial Update: A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating prophylactic central neck dissection in low-risk papillary thyroid cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Cancer
• Thyroid Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Thyroid Cancer, Recurrence | Phase 3 | Status: RECRUITING